Looking into the Future: Reproductive Health in Sickle Cell Disease
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Pediatric Hematology-Oncology Research Seminar Series session will take place on Thursday, March 2, 2023 at 8:00 a.m. and has been approved for CME and Ethics Credit. Live attendance for this session will only be available through Zoom.
Activity Information
Needs Statement
Clinical and research faculty, graduate and medical students, clinical and postdoctoral fellows, and clinical and research nurses in pediatric hematology-oncology need to receive regular updates on the latest clinical trial data concerning hematological-oncological disorders in children and advances in targeted therapies for these disorders. Learners also need regular reviews of the ethical and legal issues surrounding end-of-life care and of the evolving practice standards for follow-up care for long-term survivors of hematological-oncological disorders. The series aims to increase the knowledge and skills of the learners to enhance the quality of healthcare, increase patient safety, and improve patient outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Discuss why reproductive health and health education programs for individuals with sickle cell trait or disease are important and emerging areas of research.
- Recognize methods for creating culturally relevant, health-literacy sensitive, and accessible health education programs for people with sickle cell trait or disease.
- Describe recent research related to reproductive health in individuals with sickle cell trait or disease.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
Specialties
- Nuclear Medicine
- Pathology
- Pediatrics
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
Activity Directors
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Susan Creary, M.D.
Associate Professor of Pediatrics, Division of Hematology, Oncology, and Blood and Marrow Transplant
Ohio State University, Nationwide Children’s Hospital
Disclosure:
Nothing to disclose.
Activity Directors
-
Terzah Horton, M.D., Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jonathan Flanagan, Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Jonathan Flanagan, Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Terzah Horton, M.D., Ph.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
YoungNa Lee-Kim, M.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Donald Williams Parsons, M.D., Ph.D.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: